U.S. market Closed. Opens in 1 day 1 hour 24 minutes

CTSO | Cytosorbents Corporation Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-05-31
Revenue36.35M29.36M40.11M39.45M22.77M20.25M13.38M8.21M4.06M3.15M821.79K151.57K36.08KN/AN/AN/AN/AN/A10.00K
Cost of Revenue13.96M13.96M11.05M11.05M7.36M7.49M5.52M3.95M2.21M2.13M1.91M319.30K11.76KN/AN/AN/AN/AN/A10.00K
Gross Profit22.39M15.40M29.06M28.40M15.40M12.76M7.86M4.25M1.84M1.01M-1.09M-167.72K24.32KN/AN/AN/AN/AN/AN/A
Operating Expenses53.60M46.93M51.81M38.77M34.38M28.35M17.71M15.74M11.15M8.29M3.62M3.32M4.46M2.82M3.03M3.24M3.07M2.96M80.00K
Selling, General & Admin36.94M37.14M38.48M31.51M24.47M22.88M15.43M12.28M8.01M6.84M3.49M1.98M1.57M1.07M1.07M1.26M1.65M1.85M70.00K
Research & Development15.73M15.12M16.38M8.81M12.09M7.72M4.05M4.78M3.87M2.43M1.74M2.53M2.89M1.76M1.96M1.98M1.42M1.11MN/A
Other Operating Expenses936.00K-5.33M-3.06M-1.55M-2.18M-2.25M-1.77M-1.32M-735.86K-2.43M-1.60M-1.19MN/AN/AN/AN/AN/AN/A10.00K
Operating Income-31.21M-31.52M-22.75M-10.37M-18.97M-15.58M-9.84M-11.49M-9.30M-7.28M-4.71M-3.49M-4.44M-2.82M-2.43M-3.24M-3.07M-2.96M-80.00K
Other Expenses / Income1.89M-2.38M-2.55M1.41M-1.38M-2.25M705.06K-589.88K847.32K-2.81M-422.84K-564.43K-1.04M5.73M12.14M-22.21K-284.12K-4.71MN/A
Before Tax Income-29.32M-33.91M-25.30M-8.96M-20.36M-17.83M-9.14M-12.26M-8.46M-9.71M-5.14M-4.06M-5.48M2.91M3.04M-3.27M-3.35M-7.67M-80.00K
Income Tax Expenses-813.74K-1.09M-736.00K-1.13M-1.09M-619.55K-676.74K-318.55K-324.61K-386.00K-458.28K-391.76K1.04M5.82M298.79K-248.53K3.35M7.67MN/A
Net Income-28.51M-32.81M-24.56M-7.84M-19.27M-17.21M-8.46M-11.94M-8.13M-9.32M-4.68M-3.66M-5.48M-2.91M-2.74M-3.02M-3.35M-7.67M-80.00K
Interest Expenses157.89K132.60KN/A1.20M1.03M1.46M749.08K231.80K9.30K310.02K422.84K564.43K1.04M84.85K8.14K22.21K-3.35M4.74MN/A
Basic Shares Outstanding44.66M43.57M43.36M38.82M32.26M30.72M27.61M25.43M24.89M14.38M9.44M7.93M6.41M3.92M1.66M1.00M993.94K598.24K310.00K
Diluted Shares Outstanding44.66M43.57M43.36M38.82M32.26M30.72M27.61M25.43M24.89M14.38M9.44M7.93M6.41M3.92M1.66M1.00M993.94K598.24K310.00K
EBITDA-28.81M-30.00M-22.01M-9.71M-18.74M-15.98M-8.17M-11.86M-9.19M-6.83M-4.65M-3.44M-4.40M-2.81M-2.98M-3.14M-3.16M-1.74M-70.00K
EBITDA Margin-79.26%-102.19%-54.88%-24.61%-82.33%-78.90%-61.05%-144.58%-226.61%-217.08%-565.70%-2,267.03%-12,185.13%0.00%0.00%0.00%0.00%0.00%-700.00%
EBIT-29.16M-33.77M-25.30M-7.76M-19.32M-16.37M-8.39M-12.03M-8.45M-9.40M-4.71M-3.49M-3.39M2.99M-2.43M-3.24M-3.35M4.74M-80.00K
EBIT Margin-80.23%-115.03%-63.07%-19.68%-84.88%-80.83%-62.69%-146.55%-208.27%-298.79%-573.53%-2,303.06%-9,401.54%0.00%0.00%0.00%0.00%0.00%-800.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-05-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙